Treatment

NMS-01940153E clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
Phase II Combination Study of NMS-01940153E and Atezolizumab with or without a prior priming with low dose decitabine for the Treatment of Adult Patients with Unresectable Hepatocellular Carcinoma (HCC) Previously Treated with Immune Checkpoint Inhibitors
This study is testing a new combination of medicines for adults with liver cancer that has spread too widely to be removed by surgery. It's for people whose cancer has already been treated with a type of immunotherapy. Researchers want to see how well these new combinations work.
For: Unresectable Hepatocellular Carcinoma (HCC)
Spain · Italy